Company news

Bionano Genomics, Inc. (NASDAQ:BNGO) news

Every Bionano Genomics, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.

View Bionano Genomics, Inc. stock analysis →

Press releases & updates

Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

August 24, 2026

Bionano Reports Second Quarter 2026 Results and Provides a Business Update

August 10, 2026

Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026

July 27, 2026

Bionano Announces Hiring of Chief Scientific Officer

June 24, 2026

Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption

June 18, 2026

Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic D...

June 11, 2026

Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures

May 28, 2026

Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia

May 26, 2026

Bionano Reports First Quarter 2026 Results and Provides a Business Update

May 13, 2026

Bionano Announces Leadership Transition

May 6, 2026

Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025

May 5, 2026

Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026

April 29, 2026

Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multi...

April 2, 2026

Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026

March 23, 2026

Bionano Announces Two-Fold Increase in OGM Studies Presented at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual ...

March 17, 2026

Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026

March 9, 2026

Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale

February 27, 2026

10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Di...

February 26, 2026

11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene T...

February 25, 2026

9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies

February 24, 2026

Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping

February 9, 2026

Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations...

February 4, 2026

Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results

January 12, 2026

Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025

December 11, 2025

Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematol...

December 3, 2025

Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress

November 13, 2025

Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia

November 6, 2025

Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025

October 30, 2025

Bionano Highlights Global Momentum Behind OGM at the 2025 Annual Meeting of the American Society of Human Genetics (ASHG) Meeting

October 23, 2025

Bionano to Participate in the H.C. Wainwright @ Home Event

October 7, 2025

Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering

September 17, 2025

Bionano Genomics, Inc. Announces Pricing of $10 Million Public Offering

September 16, 2025

Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Mo...

September 16, 2025

CMS Posts Preliminary Payment Determination for New Category I CPT Code Covering Use of OGM for Constitutional Genetic Disorders

September 15, 2025

Bionano to Present at the H.C. Wainwright 27th Annual Global Investment Conference

August 25, 2025

Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress

August 14, 2025

Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL

August 7, 2025

Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference

August 6, 2025

Bionano Announces Upgrades to its Software and Compute Platforms to Make Analysis of OGM, Microarray and NGS Data Easier, Faster and More...

August 5, 2025

Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025

July 31, 2025

Bionano Recaps Momentum behind Optical Genome Mapping at the Biennial Meeting of the European Cytogenomics Association Held Recently in L...

July 30, 2025

Bionano Recaps Global Momentum Behind Optical Genome Mapping at the 2025 Annual Meeting of the European Society of Human Genetics Held Re...

June 18, 2025

Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress

May 14, 2025

Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025

May 7, 2025

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogen...

May 2, 2025

Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Const...

April 23, 2025

Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM

April 8, 2025

Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025

March 31, 2025

Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating...

March 24, 2025

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting

March 18, 2025

Older →